EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹498 Cr | ₹532 Cr | ₹662 Cr | ₹392 Cr | ₹84 Cr |
What is the latest Consolidated Net Profit of EMCURE PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹498 Cr |
Mar2023 | ₹532 Cr |
Mar2022 | ₹662 Cr |
Mar2021 | ₹392 Cr |
Mar2020 | ₹84 Cr |
How is Consolidated Net Profit of EMCURE PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹498 Cr | -6.36 | |
Mar2023 | ₹532 Cr | -19.66 | |
Mar2022 | ₹662 Cr | 68.87 | |
Mar2021 | ₹392 Cr | 369.04 | |
Mar2020 | ₹84 Cr | - |
Compare Consolidated Net Profit of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹18,700.8 Cr | -1.2% | 8.2% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | 2.3% | 11.7% | 5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -1.6% | 4% | 58.7% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | 0.8% | 6.2% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 0.7% | 9.8% | 19.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -1% | 2.8% | -8% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | -1.2% |
8.2% |
|
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses